A hypoxia-on-a-chip platform for modeling ischemic arrhythmogenesis and evaluating the effects of levosimendan and OR-1896 on ischemic human iPSC-derived cardiomyocytesFRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGYIF4.82025-09-290OA
Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and VomitingJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82023-03-012OAAI
The reverse mode of the Na+/Ca2+ exchanger contributes to the pacemaker mechanism in rabbit sinus node cellsSCIENTIFIC REPORTSIF3.92022-12-173OAAI
Blockade of sodium-calcium exchanger via ORM-10962 attenuates cardiac alternansJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72021-04-0112OAAI
Discovery and characterization of ORM-11372, a novel inhibitor of the sodium-calcium exchanger with positive inotropic activityBRITISH JOURNAL OF PHARMACOLOGYIF7.72020-11-1013OAAI
Ocular drops of palonosetron reduce chemotherapy-induced acute nausea and vomiting in the dogCANCER RESEARCHIF16.62020-08-150PRE
Long-term effects of Na+/Ca2+ exchanger inhibition with ORM-11035 improves cardiac function and remodelling without lowering blood pressure in a model of heart failure with preserved ejection fractionEUROPEAN JOURNAL OF HEART FAILUREIF10.82019-11-2426OAAI
Complex electrophysiological remodeling in postinfarction ischemic heart failure梗死后缺血性心力衰竭的复杂电生理重构PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12018-03-1275OAAI
Inotropic effect of NCX inhibition depends on the relative activity of the reverse NCX assessed by a novel inhibitor ORM-10962 on canine ventricular myocytesEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72018-01-0112OAAI
ORM-3819 promotes cardiac contractility through Ca2+ sensitization in combination with selective PDE III inhibition, a novel approach to inotropyEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72016-03-016OAAI
Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusionHEARTIF4.42016-01-1311PREAI
Exacerbation of acute kidney injury by bone marrow stromal cells from rats with persistent renin-angiotensin system activationCLINICAL SCIENCEIF7.72015-03-178PREAI
Levosimendan alone and in combination with valsartan prevents stroke in Dahl salt-sensitive ratsEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72015-03-017OAAI
Efficacy of selective NCX inhibition by ORM-10103 during simulated ischemia/reperfusionEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72014-10-0121OAAI
ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heartBRITISH JOURNAL OF PHARMACOLOGYIF7.72013-10-0171OAAI
AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidneyBRITISH JOURNAL OF PHARMACOLOGYIF7.72012-06-27106OAAI
Discovery and Structural Characterization of a Phospholamban-Binding Cyclic Peptide and Design of Novel Inhibitors of PhospholambanCHEMICAL BIOLOGY & DRUG DESIGNIF3.32012-06-065PREAI
Caloric Restriction Ameliorates Angiotensin II-Induced Mitochondrial Remodeling and Cardiac HypertrophyHYPERTENSIONIF8.22012-01-0157OAAI
Intramyocardial BNP Gene Delivery Improves Cardiac Function Through Distinct Context-Dependent Mechanismsjacc heart failureIF8.42011-07-0152OAAI